Cargando…
Neocytolysis: none, one or many? A reappraisal and future perspectives
Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astro...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924315/ https://www.ncbi.nlm.nih.gov/pubmed/24592241 http://dx.doi.org/10.3389/fphys.2014.00054 |
_version_ | 1782303724414173184 |
---|---|
author | Risso, Angela Ciana, Annarita Achilli, Cesare Antonutto, Guglielmo Minetti, Giampaolo |
author_facet | Risso, Angela Ciana, Annarita Achilli, Cesare Antonutto, Guglielmo Minetti, Giampaolo |
author_sort | Risso, Angela |
collection | PubMed |
description | Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astronauts during the first days of spaceflight under weightlessness, where a fast reduction in plasma volume and increase in haematocrit occur. EPO plasma levels then decline and a decrease in RBC mass takes place, apparently because of the selective lysis of the youngest, recently generated RBCs (neocytes). The same process seems to occur in people descending to sea level after acclimatization at high altitude. After descent, the polycythaemia developed at high altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs. In vivo, neocytolysis seems to be abolished by EPO administration. More recent research has ascribed to neocytolysis the RBC destruction that occurs under such disparate pathophysiologic conditions as nephropathy, severe obstructive pulmonary disease, blood doping, and even malaria anaemia. According to the theory, EPO's central role would be not only to stimulate the production of new RBCs in conditions of anaemia, as maintained by the orthodox view, but also that of a cytoprotective factor for circulating young RBCs. Why neocytes are specifically destroyed and how is this related to decreased EPO levels has not yet been elucidated. Changes in membrane molecules of young RBCs isolated from astronauts or mountain climbers upon return to normal conditions seem to indicate a higher susceptibility of neocytes to ingestion by macrophages. By limiting the context to space missions and high altitude expeditions, this review will address unresolved and critical issues that in our opinion have not been sufficiently highlighted in previous works. |
format | Online Article Text |
id | pubmed-3924315 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-39243152014-03-03 Neocytolysis: none, one or many? A reappraisal and future perspectives Risso, Angela Ciana, Annarita Achilli, Cesare Antonutto, Guglielmo Minetti, Giampaolo Front Physiol Physiology Neocytolysis is the hypothesis formulated to explain experimental evidence of selective lysis of young red blood cells (RBCs) (neocytes) associated with decreased plasma levels of erythropoietin (EPO). In humans, it appears to take place whenever a fast RBC mass reduction is required, i.e., in astronauts during the first days of spaceflight under weightlessness, where a fast reduction in plasma volume and increase in haematocrit occur. EPO plasma levels then decline and a decrease in RBC mass takes place, apparently because of the selective lysis of the youngest, recently generated RBCs (neocytes). The same process seems to occur in people descending to sea level after acclimatization at high altitude. After descent, the polycythaemia developed at high altitude must be abrogated, and a rapid reduction in the number of circulating RBCs is obtained by a decrease in EPO synthesis and the lysis of what seem to be young RBCs. In vivo, neocytolysis seems to be abolished by EPO administration. More recent research has ascribed to neocytolysis the RBC destruction that occurs under such disparate pathophysiologic conditions as nephropathy, severe obstructive pulmonary disease, blood doping, and even malaria anaemia. According to the theory, EPO's central role would be not only to stimulate the production of new RBCs in conditions of anaemia, as maintained by the orthodox view, but also that of a cytoprotective factor for circulating young RBCs. Why neocytes are specifically destroyed and how is this related to decreased EPO levels has not yet been elucidated. Changes in membrane molecules of young RBCs isolated from astronauts or mountain climbers upon return to normal conditions seem to indicate a higher susceptibility of neocytes to ingestion by macrophages. By limiting the context to space missions and high altitude expeditions, this review will address unresolved and critical issues that in our opinion have not been sufficiently highlighted in previous works. Frontiers Media S.A. 2014-02-14 /pmc/articles/PMC3924315/ /pubmed/24592241 http://dx.doi.org/10.3389/fphys.2014.00054 Text en Copyright © 2014 Risso, Ciana, Achilli, Antonutto and Minetti. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Physiology Risso, Angela Ciana, Annarita Achilli, Cesare Antonutto, Guglielmo Minetti, Giampaolo Neocytolysis: none, one or many? A reappraisal and future perspectives |
title | Neocytolysis: none, one or many? A reappraisal and future perspectives |
title_full | Neocytolysis: none, one or many? A reappraisal and future perspectives |
title_fullStr | Neocytolysis: none, one or many? A reappraisal and future perspectives |
title_full_unstemmed | Neocytolysis: none, one or many? A reappraisal and future perspectives |
title_short | Neocytolysis: none, one or many? A reappraisal and future perspectives |
title_sort | neocytolysis: none, one or many? a reappraisal and future perspectives |
topic | Physiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924315/ https://www.ncbi.nlm.nih.gov/pubmed/24592241 http://dx.doi.org/10.3389/fphys.2014.00054 |
work_keys_str_mv | AT rissoangela neocytolysisnoneoneormanyareappraisalandfutureperspectives AT cianaannarita neocytolysisnoneoneormanyareappraisalandfutureperspectives AT achillicesare neocytolysisnoneoneormanyareappraisalandfutureperspectives AT antonuttoguglielmo neocytolysisnoneoneormanyareappraisalandfutureperspectives AT minettigiampaolo neocytolysisnoneoneormanyareappraisalandfutureperspectives |